{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:14:09Z","timestamp":1794863649891,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770215"],"award-info":[{"award-number":["81770215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic myelogenous leukemia (CML) is a clonal malignancy of hematopoietic stem cells featured with the fusion protein kinase BCR-ABL. To elicit the mechanism underlying BCR-ABL stability, we perform a screen against a panel of deubiquitinating enzymes (DUBs) and find that the ubiquitin-specific protease 7 (USP7) drastically stabilizes the BCR-ABL fusion protein. Further studies show that USP7 interacts with BCR-ABL and blocks its polyubiquitination and degradation. Moreover, USP7 knockdown triggers BCR-ABL degradation and suppresses its downstream signaling transduction. In line with this finding, genetic or chemical inhibition of USP7 leads to BCR-ABL protein degradation, suppresses BCR\/ABL signaling, and induces CML cell apoptosis. Furthermore, we find the antimalarial artesunate (ART) significantly inhibits USP7\/BCR-ABL interaction, thereby promoting BCR-ABL degradation and inducing CML cell death. This study thus identifies USP7 as a putative Dub of BCR-ABL and provides a rationale in targeting USP7\/BCR-ABL for the treatment of CML.<\/jats:p>","DOI":"10.1038\/s41419-021-03732-6","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T17:04:12Z","timestamp":1620407052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Shuoyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-0559","authenticated-orcid":false,"given":"Hongbiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"3732_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1056\/NEJM199907153410306","volume":"341","author":"S Faderl","year":"1999","unstructured":"Faderl, S. et al. The biology of chronic myeloid leukemia. N. Engl. J. Med. 341, 164\u2013172 (1999).","journal-title":"N. Engl. J. Med"},{"key":"3732_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01630378","volume":"8","author":"PC Nowell","year":"1962","unstructured":"Nowell, P. C. The minute chromosome (Phl) in chronic granulocytic leukemia. Blut 8, 65\u201366 (1962).","journal-title":"Blut"},{"key":"3732_CR3","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","volume":"112","author":"BJ Druker","year":"2008","unstructured":"Druker, B. J. Translation of the Philadelphia chromosome into therapy for CML. Blood 112, 4808\u20134817 (2008).","journal-title":"Blood"},{"key":"3732_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","volume":"18","author":"D Cilloni","year":"2012","unstructured":"Cilloni, D. & Saglio, G. Molecular pathways: BCR-ABL. Clin. Cancer Res. 18, 930\u2013937 (2012).","journal-title":"Clin. Cancer Res"},{"key":"3732_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.leukres.2013.12.025","volume":"38","author":"MH Elias","year":"2014","unstructured":"Elias, M. H. et al. BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome. Leuk. Res. 38, 454\u2013459 (2014).","journal-title":"Leuk. Res"},{"key":"3732_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876\u2013880 (2001).","journal-title":"Science"},{"key":"3732_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1073\/pnas.040547997","volume":"97","author":"N Kashige","year":"2000","unstructured":"Kashige, N., Carpino, N. & Kobayashi, R. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Proc. Natl Acad. Sci. USA 97, 2093\u20132098 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3732_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200544090-00001","volume":"44","author":"B Peng","year":"2005","unstructured":"Peng, B., Lloyd, P. & Schran, H. Clinical pharmacokinetics of imatinib. Clin. Pharmacokinet. 44, 879\u2013894 (2005).","journal-title":"Clin. Pharmacokinet."},{"key":"3732_CR9","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1158\/0008-5472.CAN-17-1733","volume":"78","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. Antitumor effects of blocking protein neddylation in T315I-BCR-ABL leukemia cells and leukemia stem cells. Cancer Res. 78, 1522\u20131536 (2018).","journal-title":"Cancer Res."},{"key":"3732_CR10","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1158\/0008-5472.CAN-19-1236","volume":"79","author":"GM Burslem","year":"2019","unstructured":"Burslem, G. M. et al. Targeting BCR-ABL1 in chronic myeloid leukemia by PROTAC-mediated targeted protein degradation. Cancer Res. 79, 4744\u20134753 (2019).","journal-title":"Cancer Res."},{"key":"3732_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep41525","volume":"7","author":"H Huang","year":"2017","unstructured":"Huang, H. et al. Oridonin triggers chaperon-mediated proteasomal degradation of BCR-ABL in leukemia. Sci. Rep. 7, 41525 (2017).","journal-title":"Sci. Rep."},{"key":"3732_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep28352","volume":"6","author":"Y Ru","year":"2016","unstructured":"Ru, Y. et al. The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL. Sci. Rep. 6, 28352 (2016).","journal-title":"Sci. Rep."},{"key":"3732_CR13","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1038\/s41388-020-1253-0","volume":"39","author":"N Shibata","year":"2020","unstructured":"Shibata, N. et al. Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells. Oncogene 39, 3867\u20133878 (2020).","journal-title":"Oncogene"},{"key":"3732_CR14","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.3892\/ol.2016.5073","volume":"12","author":"G Carr\u00e0","year":"2016","unstructured":"Carr\u00e0, G. et al. The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia. Oncol. Lett. 12, 3123\u20133126 (2016).","journal-title":"Oncol. Lett."},{"key":"3732_CR15","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1182\/blood-2010-03-276477","volume":"117","author":"H Sun","year":"2011","unstructured":"Sun, H. et al. Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis. Blood 117, 3151\u20133162 (2011).","journal-title":"Blood"},{"key":"3732_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-016-0359-x","volume":"9","author":"X Lan","year":"2016","unstructured":"Lan, X. et al. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr\/Abl-dependent and Bcr\/Abl-independent mechanisms. J. Hematol. Oncol. 9, 129 (2016).","journal-title":"J. Hematol. Oncol."},{"key":"3732_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1158\/1078-0432.CCR-13-1063","volume":"20","author":"X Shi","year":"2014","unstructured":"Shi, X. et al. Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. Clin. Cancer Res. 20, 151\u2013163 (2014).","journal-title":"Clin. Cancer Res"},{"key":"3732_CR18","doi-asserted-by":"publisher","first-page":"e1005764","DOI":"10.1371\/journal.ppat.1005764","volume":"12","author":"Y Ren","year":"2016","unstructured":"Ren, Y. et al. Deubiquitinase USP2a sustains interferons antiviral activity by restricting ubiquitination of activated STAT1 in the nucleus. PLoS Pathog. 12, e1005764 (2016).","journal-title":"PLoS Pathog."},{"key":"3732_CR19","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1074\/jbc.RA119.010724","volume":"295","author":"Y He","year":"2020","unstructured":"He, Y. et al. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. J. Biol. Chem. 295, 2084\u20132096 (2020).","journal-title":"J. Biol. Chem."},{"key":"3732_CR20","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1182\/blood-2015-07-658203","volume":"127","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice. Blood 127, 1676\u20131686 (2016).","journal-title":"Blood"},{"key":"3732_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.biocel.2014.10.024","volume":"57","author":"G Chen","year":"2014","unstructured":"Chen, G. et al. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues. Int. J. Biochem. Cell Biol. 57, 157\u2013166 (2014).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"3732_CR22","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood.2020005199","volume":"137","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Targeting the Otub1\/c-Maf axis for the treatment of multiple myeloma. Blood 137, 1478\u20131490 (2021).","journal-title":"Blood"},{"key":"3732_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.450","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. Cell Death Dis. 8, e3058 (2017).","journal-title":"Cell Death Dis."},{"key":"3732_CR24","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41401-019-0249-1","volume":"40","author":"XH Chen","year":"2019","unstructured":"Chen, X. H. et al. Mebendazole elicits potent antimyeloma activity by inhibiting the USP5\/c-Maf axis. Acta Pharm. Sin. 40, 1568\u20131577 (2019).","journal-title":"Acta Pharm. Sin."},{"key":"3732_CR25","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/leu.2013.370","volume":"28","author":"A Morotti","year":"2014","unstructured":"Morotti, A. et al. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP. Leukemia 28, 1326\u20131333 (2014).","journal-title":"Leukemia"},{"key":"3732_CR26","doi-asserted-by":"publisher","first-page":"32886","DOI":"10.1074\/jbc.M113.496331","volume":"288","author":"KW Lee","year":"2013","unstructured":"Lee, K. W. et al. Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor gamma (PPARgamma) stability through its deubiquitinating activity. J. Biol. Chem. 288, 32886\u201332896 (2013).","journal-title":"J. Biol. Chem."},{"key":"3732_CR27","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2007-08-109330","volume":"111","author":"J Wu","year":"2008","unstructured":"Wu, J. et al. Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells. Blood 111, 3821\u20133829 (2008).","journal-title":"Blood"},{"key":"3732_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","volume":"22","author":"D Chauhan","year":"2012","unstructured":"Chauhan, D. et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22, 345\u2013358 (2012).","journal-title":"Cancer Cell"},{"key":"3732_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/jnci\/djx236","volume":"110","author":"R Mitchell","year":"2018","unstructured":"Mitchell, R. et al. Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition. J. Natl Cancer Inst. 110, 467\u2013478 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"3732_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vph.2007.05.002","volume":"47","author":"HJ Zhou","year":"2007","unstructured":"Zhou, H. J., Wang, W. Q., Wu, G. D., Lee, J. & Li, A. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells. Vasc. Pharm. 47, 131\u2013138 (2007).","journal-title":"Vasc. Pharm."},{"key":"3732_CR31","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/ncb1469","volume":"8","author":"A van der Horst","year":"2006","unstructured":"van der Horst, A. et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7\/HAUSP. Nat. Cell Biol. 8, 1064\u20131073 (2006).","journal-title":"Nat. Cell Biol."},{"key":"3732_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nature07290","volume":"455","author":"MS Song","year":"2008","unstructured":"Song, M. S. et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813\u2013817 (2008).","journal-title":"Nature"},{"key":"3732_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-019-0092-z","volume":"5","author":"Y Liao","year":"2019","unstructured":"Liao, Y. et al. USP10 modulates the SKP2\/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia. Cell Disco. 5, 24 (2019).","journal-title":"Cell Disco."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03732-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:01:39Z","timestamp":1669971699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03732-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["3732"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03732-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was partly supported by the National Natural Science Foundation of China (#81770154 and #81970194 to X.M. and #81770215 to B.C.), Natural Science Foundation Research Team of Guangdong Province (2018B030312001 to J.L. and H.H.), by Suzhou Municipal Science and Technology Project (#SYS201702 to B.C.), and by Guangzhou Municipal Science and Technology Project (#202002030059 to X.M.). X.M. is a Nanshan Scholar of Guangzhou Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"456"}}